Mark W. Hahn
Net Worth

Last updated:

What is Mark W. Hahn net worth?

The estimated net worth of Mr. Mark W. Hahn is at least $1,420,199,836 as of 6 Dec 2024. He owns shares worth $1,400,096,276 as insider, has earned $17,863,280 from insider trading and has received compensation worth at least $2,240,280 in Verona Pharma plc.

What is the salary of Mark W. Hahn?

Mr. Mark W. Hahn salary is $560,070 per year as Chief Financial Officer in Verona Pharma plc.

How old is Mark W. Hahn?

Mr. Mark W. Hahn is 62 years old, born in 1963.

What stocks does Mark W. Hahn currently own?

As insider, Mr. Mark W. Hahn owns shares in one company:

Company Title Shares Price per share Total value
Verona Pharma plc (VRNA) Chief Financial Officer 13,293,736 $105.32 $1,400,096,276

What does Verona Pharma plc do?

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom.

VRNA logo
VRNA
Verona Pharma plc
$105.32

Mark W. Hahn insider trading

Verona Pharma plc

Mr. Mark W. Hahn has made 37 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he sold 183,728 units of VRNA stock worth $920,294 on 6 Dec 2024.

The largest trade he's ever made was exercising 640,048 units of VRNA stock on 5 Dec 2024. As of 6 Dec 2024 he still owns at least 13,293,736 units of VRNA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Ordinary Shares 183,728 $5.01 $920,294
Sale
Ordinary Shares 640,048 $5.01 $3,204,080
Sale
Ordinary Shares 58,184 $5 $290,978
Sale
Ordinary Shares 1,600 $5 $8,000
Sale
Ordinary Shares 98,704 $5.01 $494,112
Sale
Ordinary Shares 12,936 $5 $64,680
Sale
Ordinary Shares 800 $5 $4,000
Sale
Ordinary Shares 1,600 $5 $8,000
Sale
Ordinary Shares 2,400 $5 $12,000
Sale
Ordinary Shares 80,784 $4.39 $354,480
Sale
Ordinary Shares 48,888 $4.38 $213,934
Sale
Ordinary Shares 3,200 $4.38 $14,000
Sale
Ordinary Shares 141,360 $4.38 $618,733
Sale
Ordinary Shares 159,344 $4.39 $698,723
Sale
Ordinary Shares 116,696 $4.38 $511,128
Sale
Ordinary Shares 249,728 $4.38 $1,094,058
Sale
Ordinary Shares 600,000 $3.76 $2,254,200
Sale
Ordinary Shares 394,664 $3.2 $1,263,319
Sale
Ordinary Shares 3,736 $3.25 $12,142
Sale
Ordinary Shares 1,600 $3.13 $5,008
Sale
Ordinary Shares 8,616 $2.47 $21,264
Sale
Ordinary Shares 150,000 $2.5 $374,850
Sale
Ordinary Shares 117,272 $2.54 $297,754
Sale
Ordinary Shares 73,704 $2.59 $191,114
Sale
Ordinary Shares 105,944 $2.68 $283,824
Sale
Ordinary Shares 455,528 $2.58 $1,173,440
Sale
Ordinary Shares 413,168 $2.56 $1,056,471
Sale
Ordinary Shares 600,000 $2.12 $1,269,000
Sale
Ordinary Shares 13,160 $1.67 $22,017
Sale
Ordinary Shares 600,000 $1.75 $1,050,000
Sale
Ordinary Shares 13,168 $0.7 $9,218
Sale
Ordinary Shares 12,512 $0.5 $6,206
Sale
Ordinary Shares 10,416 $0.76 $7,874
Sale
Ordinary Shares 10,416 $0.65 $6,718
Sale
Ordinary Shares 10,416 $0.77 $7,989
Sale
Ordinary Shares 10,416 $0.87 $9,093
Sale
Ordinary Shares 26,728 $1.14 $30,577

Verona Pharma key executives

Verona Pharma plc executives and other stock owners filed with the SEC: